This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Oct;79(4):e154-e155.

doi: 10.1016/j.jhep.2023.01.021. Epub 2023 Feb 1.

A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Has the correct patient cohort been targeted?

Sinead Carlson¹, Karl Vaz², Adam Peterson³

Affiliations

Affiliations

¹ Department of Gastroenterology, Monash Health, School of Clinical Sciences, Monash University, Australia. Electronic address: sinead.carlson@monashhealth.org.
² Department of Gastroenterology, Alfred Health, Central Clinical School, Monash University, Australia; Department of Gastroenterology, Austin Health, Australia.
³ Department of Gastroenterology, Monash Health, School of Clinical Sciences, Monash University, Australia.

PMID: 36736735
DOI: 10.1016/j.jhep.2023.01.021

Comment

A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Has the correct patient cohort been targeted?

Sinead Carlson et al. J Hepatol. 2023 Oct.

. 2023 Oct;79(4):e154-e155.

doi: 10.1016/j.jhep.2023.01.021. Epub 2023 Feb 1.

Authors

Sinead Carlson¹, Karl Vaz², Adam Peterson³

Affiliations

¹ Department of Gastroenterology, Monash Health, School of Clinical Sciences, Monash University, Australia. Electronic address: sinead.carlson@monashhealth.org.
² Department of Gastroenterology, Alfred Health, Central Clinical School, Monash University, Australia; Department of Gastroenterology, Austin Health, Australia.
³ Department of Gastroenterology, Monash Health, School of Clinical Sciences, Monash University, Australia.

PMID: 36736735
DOI: 10.1016/j.jhep.2023.01.021

No abstract available

PubMed Disclaimer

Comment in

Reply to: 'A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Has the correct patient cohort been targeted?'.
Yang H, Kim JH, Han JW, Lee SK, Jang JW. Yang H, et al. J Hepatol. 2023 Oct;79(4):e155-e157. doi: 10.1016/j.jhep.2023.06.005. Epub 2023 Jun 27. J Hepatol. 2023. PMID: 37385474 No abstract available.

Comment on

A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
Yang H, Bae SH, Nam H, Lee HL, Lee SW, Yoo SH, Song MJ, Kwon JH, Nam SW, Choi JY, Yoon SK, Jang JW. Yang H, et al. J Hepatol. 2022 Sep;77(3):632-641. doi: 10.1016/j.jhep.2022.03.032. Epub 2022 Apr 7. J Hepatol. 2022. PMID: 35398462

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information